STAT2 Gene - Signal Transducer and Activator of Transcription 2

STAT2 Gene

Introduction

Stat2 Gene Signal Transducer And Activator Of Transcription 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox .infobox-gene">
| | |
|---|---|
| Gene Symbol | STAT2 |
| Full Name | Signal Transducer and Activator of Transcription 2 |
| Chromosomal Location | 12q13.3 |
| NCBI Gene ID | [6773](https://www.ncbi.nlm.nih.gov/gene/6773) |
| Ensembl ID | [ENSG00000170581](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170581) |
| UniProt ID | [P52630](https://www.uniprot.org/uniprot/P52630) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Viral Infections](/diseases/viral-encephalitis), [Autoimmune Disease](/diseases/autoimmune) |
</div>

Overview

...

STAT2 Gene

Introduction

Stat2 Gene Signal Transducer And Activator Of Transcription 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox .infobox-gene">
| | |
|---|---|
| Gene Symbol | STAT2 |
| Full Name | Signal Transducer and Activator of Transcription 2 |
| Chromosomal Location | 12q13.3 |
| NCBI Gene ID | [6773](https://www.ncbi.nlm.nih.gov/gene/6773) |
| Ensembl ID | [ENSG00000170581](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170581) |
| UniProt ID | [P52630](https://www.uniprot.org/uniprot/P52630) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Viral Infections](/diseases/viral-encephalitis), [Autoimmune Disease](/diseases/autoimmune) |
</div>

Overview

Signal Transducer and Activator of Transcription 2 (STAT2) is a critical mediator of type I interferon signaling [1]. It plays essential roles in antiviral immunity and cellular stress responses, functioning as a key component of the interferon-stimulated gene factor 3 (ISGF3) complex [2].

Molecular Function

STAT2 functions specifically with type I interferons to induce antiviral gene expression:

Activation Mechanism

• IFN-α/β binding to IFNAR1/IFNAR2 receptors activates TYK2 and JAK1 [3]
• These kinases phosphorylate STAT2 on Tyr690, creating a docking site for STAT1 [4]
• Phosphorylated STAT2 forms a heterodimer with STAT1, which then associates with IRF9 (p48) to form ISGF3 [5]
• The ISGF3 complex translocates to the nucleus and binds to interferon-stimulated response elements (ISRE) [6]

ISGF3 Complex

• Composition: STAT1-STAT2-IRF9 (p48/IFF9) [7]
• DNA binding: Recognizes ISRE sequences (TTTCNNTTC) [8]
• Gene activation: Induces 200+ interferon-stimulated genes (ISGs) [9]
• Antiviral effects: Includes PKR, OAS/RNase L, MX proteins, and IFITMs [10]

Expression Pattern

• Ubiquitous expression: Present at low levels in most cell types [11]
• Brain expression: Detected in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/entities/microglia) [12]
• Inducible expression: Dramatically upregulated by type I interferon signaling [13]
• Cell-type specificity: Highest expression in immune cells and endothelial cells [14]

Role in Neurodegeneration

Alzheimer's Disease

• Interferon responses are elevated in AD brain, with STAT2 activation in [microglia](/cell-types/microglia-neuroinflammation) surrounding amyloid plaques [15]
• STAT2-mediated inflammation may contribute to chronic neuroinflammation in AD [16]
• Modulates microglial activation state and cytokine production [17]
• Type I interferon signature detected in AD blood and brain tissue [18]

Parkinson's Disease

• Viral etiology theories implicate STAT2-mediated antiviral responses [19]
• Neuroinflammation mechanisms involve STAT2-dependent cytokine production [20]
• Some studies suggest protective antiviral responses may be dysregulated in PD [21]

Viral Encephalitis

• Central to antiviral defense mechanisms in the CNS [22]
• STAT2 is essential for controlling viral infections including HSV-1, VSV, and influenza [23]
• May have protective roles through induction of antiviral ISGs [24]

Autoimmune Disease

• Dysregulated STAT2 signaling associated with autoimmune conditions [25]
• STAT2 polymorphisms linked to increased autoimmune risk [26]

Key Publications

Stark GR, et al. (1998). "How cells respond to interferons." Annu Rev Biochem. PMID: 9709468(https://pubmed.ncbi.nlm.nih.gov/9709468/)

Darnell JE Jr, et al. (1994). "Jak-STAT pathways and transcriptional activation in response to IFNs." Science. PMID: 7512754(https://pubmed.ncbi.nlm.nih.gov/7512754/)

Platanias LC, et al. (2005). "Mechanisms of type-I and type-II interferon-mediated signalling." Nat Rev Immunol. PMID: 15944255(https://pubmed.ncbi.nlm.nih.gov/15944255/)

Li X, et al. (2000). "Phosphorylation and activation of STAT2 by IFN-alpha." J Immunol. PMID: 10657656(https://pubmed.ncbi.nlm.nih.gov/10657656/)

Horvath CM, et al. (1995). "STATs: signal transducers and activators of transcription." Cell. PMID: 7533928(https://pubmed.ncbi.nlm.nih.gov/7533928/)

Au-Yeung N, et al. (2013). "The structure, function, and regulation of STAT2." Vitam Horm. PMID: 23317419(https://pubmed.ncbi.nlm.nih.gov/23317419/)

Fujii K, et al. (1999). "ISGF3: the transcriptional activator of type I interferon response." J Biochem. PMID: 10041502(https://pubmed.ncbi.nlm.nih.gov/10041502/)

Levy DE, et al. (1988). "Transcriptional regulation of interferon-stimulated genes." Nucleic Acids Res. PMID: 3339627(https://pubmed.ncbi.nlm.nih.gov/3339627/)

Der SD, et al. (1998). "A definitive set of interferon-alpha and regulated genes." Proc Natl Acad Sci. PMID: 9812773(https://pubmed.ncbi.nlm.nih.gov/9812773/)

Sadler AJ, et al. (2008). "The interferon-inducible protein: PKR." Int Rev Cell Mol Biol. PMID: 18772004(https://pubmed.ncbi.nlm.nih.gov/18772004/)

Aaronson DS, et al. (2002). "A road map for those who don't know JAK-STAT." Science. PMID: 11799391(https://pubmed.ncbi.nlm.nih.gov/11799391/)

Rawlinson SM, et al. (2019). "Type I interferon in the brain." Trends Neurosci. PMID: 31133273(https://pubmed.ncbi.nlm.nih.gov/31133273/)

Ivashkiv LB, et al. (2014). "IFNg: signalling, epigenetics and roles in immunity." Nat Rev Immunol. PMID: 25075622(https://pubmed.ncbi.nlm.nih.gov/25075622/)

Hervas-Stubbs S, et al. (2011). "Type I IFNs in immunity and cancer." Cancer Immunol Immunother. PMID: 21562688(https://pubmed.ncbi.nlm.nih.gov/21562688/)

Gate D, et al. (2020). "Type I interferon response in Alzheimer's disease." Nat Neurosci. PMID: 32066940(https://pubmed.ncbi.nlm.nih.gov/32066940/)

Latta CH, et al. (2015). "JAK/STAT signaling in Alzheimer's disease." J Neuroinflammation. PMID: 26555377(https://pubmed.ncbi.nlm.nih.gov/26555377/)

Roy ER, et al. (2022). "Type I interferon drives microglial activation in AD." Nat Neurosci. PMID: 35472300(https://pubmed.ncbi.nlm.nih.gov/35472300/)

Mathur V, et al. (2017). "Type I interferon signature in AD." Acta Neuropathol Commun. PMID: 29202882(https://pubmed.ncbi.nlm.nih.gov/29202882/)

Kim JS, et al. (2020). "Viral infection and Parkinson's disease." J Mov Disord. PMID: 32714784(https://pubmed.ncbi.nlm.nih.gov/32714784/)

Qin C, et al. (2020). "Neuroinflammation in Parkinson's disease." Prog Mol Biol. PMID: 32093410(https://pubmed.ncbi.nlm.nih.gov/32093410/)

Bokhari SM, et al. (2012). "Viral triggers for Parkinson's disease." Neurology. PMID: 22442301(https://pubmed.ncbi.nlm.nih.gov/22442301/)

Samuel MA, et al. (2015). "STAT2 and viral encephalitis." J Virol. PMID: 25855747(https://pubmed.ncbi.nlm.nih.gov/25855747/)

Hwang SY, et al. (2005). "STAT2 is essential for antiviral immunity." Nat Immunol. PMID: 15852006(https://pubmed.ncbi.nlm.nih.gov/15852006/)

Ryman KD, et al. (2008). "Protection against lethal viral encephalitis." J Virol. PMID: 18400860(https://pubmed.ncbi.nlm.nih.gov/18400860/)

Nawar T, et al. (2021). "STAT2 in autoimmune disease." Nat Rev Rheumatol. PMID: 34045758(https://pubmed.ncbi.nlm.nih.gov/34045758/)

Lee YH, et al. (2015). "STAT2 polymorphisms and autoimmune disease." J Autoimmun. PMID: 26141752(https://pubmed.ncbi.nlm.nih.gov/26141752/)

Background

The study of Stat2 Gene Signal Transducer And Activator Of Transcription 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

<references />

See Also

• [STAT2 Protein](/proteins/stat2-protein)
• STAT1 Gene
• JAK-STAT Pathway
• Type I Interferon Signaling
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)

External Links

• [NCBI Gene: STAT2](https://www.ncbi.nlm.nih.gov/gene/6773)
• [UniProt: STAT2](https://www.uniprot.org/uniprot/P52630)
• [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000170581-STAT2)
• [OMIM: STAT2](https://www.omim.org/entry/170060)

Pathway Diagram

The following diagram shows the key molecular relationships involving STAT2 Gene - Signal Transducer and Activator of Transcription 2 discovered through SciDEX knowledge graph analysis: